Catatonia

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
Genetic: Genomic sequencing and molecular diagnostic results, if any.N/A1 trial
Active Trials
NCT06656572Not Yet Recruiting120Est. Sep 2030

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
GenomicsGenetic: Genomic sequencing and molecular diagnostic results, if any.

Clinical Trials (1)

Total enrollment: 120 patients across 1 trials

NCT06656572GenomicsGenetic: Genomic sequencing and molecular diagnostic results, if any.

Immunogenomic Analyses of Pediatric Catatonia

Start: Dec 2024Est. completion: Sep 2030120 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space